Meet Dr. Uzma Siddiqui

February 10, 2015

Dr. Uzma Siddiqui, MD, FASGE is the only female therapeutic endoscopist at a major academic medical center in Chicago, who leads Endoscopic Ultrasound and Advanced Endoscopy Training at the University of Chicago Medicine.

Dr. Siddiqui came to the University of Chicago Medicine in January 2012 to become a member of the Center for Endoscopic Research and Therapeutics (CERT). The center’s current Director, Dr. Irving Waxman, a world-renowned expert in therapeutic endoscopy, created CERT to be a one-of-kind program that focuses solely on innovation in advanced endoscopy through procedures, research and academic teaching. Other CERT physicians include another therapeutic endoscopist, Dr. Andres Gelrud (Director of the Pancreatic Diseases Center) and Dr. Vani Konda who leads a dedicated research section. The rest of the 25-member CERT team is comprised of nurses, physician assistants and administrative staff.

“The therapeutic endoscopists on the CERT team have all done advanced endoscopy fellowships and been in practice for at least a decade each. Together, we are one of the most experienced academic therapeutic endoscopy teams in the Chicago area,” said Dr. Siddiqui.

Her desire to pursue a career in gastroenterology and therapeutic endoscopy was inspired by her father, Dr. Dabir Siddiqui, who is also a gastroenterologist.  Dr. Siddiqui is a graduate of Wellesley College and the University of Miami School of Medicine.  She completed residency in internal medicine at George Washington University, a gastroenterology fellowship at New York University, and a fellowship in advanced endoscopy at Yale University School of Medicine before she joined the Yale faculty in 2005. 

Dr. Siddiqui’s clinical focus is on gastrointestinal oncology, which includes performing endoscopic ultrasound (EUS). She uses EUS and other therapeutic procedures to diagnose and manage a wide range of gastrointestinal cancers and pre-cancerous lesions, including pancreatic tumors. Recently, she began a new CERT program focused on endoscopic treatment of unresectable bile duct cancers using photodynamic therapy and radiofrequency ablation with endoscopic retrograde cholangiopancreatography (ERCP).

“Being diagnosed with and dealing with the symptoms of a deadly cancer is never easy, “ Siddiqui said. “But at CERT we have the unique opportunity to use our advanced endoscopic skills, innovative technology, and multi-disciplinary approach to patient care in order to provide our patients with the best possible chance at longer survival and improve their quality of life.”

The CERT team demonstrates their capabilities and highlights their state-of-the art endoscopy suite during their two live endoscopy courses held every year. These courses attract attendees and faculty from around the world. The next course will be: Live from the University of Chicago! Endoscopic Advances for Your Clinical Practice, April 17-18, 2015.

For more information on CERT, visit